Why do Monkeypox mRNA vaccines cause the same problems as Covid vaccines?

Here we reproduce a letter written to an MP by a constituent.

The letter raises concerns about the potential risks of approving future mRNA vaccines under a “platform authorisation” model whereby updates are assumed to be safe because the underlying methodology is considered safe – the way seasonal egg based influenza vaccines were regulated. This means the Monkeypox mRNA vaccines and others need not be authorised on a product-specific basis as discussed in a May 2024 MHRA Board meeting, but can piggy back on the claims made about the safety of covid vaccines. What could possibly go wrong?

Read More

When money and ethics collide

Last month, HART wrote an article on the spring booster programme, including linking to an article in Chemist+Druggist on the pending availability of private covid vaccines in pharmacies up and down the land. A company called Pharmadoctor was the first into the ring but has been followed by others including Boots, the oldest of the UK high street chemists, whose strapline on their website is: We serve your wellbeing for life.

Read More